-
BioMed X Launches Rapid Antiviral Response Platform
contractpharma
May 14, 2020
Aims to develop ultrafast new antiviral drug discovery, development and mass-manufacturing tools for rapid scale-up of new medications.
-
BioMed X Starts New Research Program in Autoimmune Diseases with Merck
b3cnewswire
January 17, 2020
BioMed X announced today the start of a new joint research group in collaboration with Merck. With this new group, BioMed X and Merck extend their ongoing collaboration to a total of six joint research projects at the BioMed X Innovation Center in Heidelb
-
BioMed X Starts New Schizophrenia Research Program with Boehringer Ingelheim
b3cnewswire
January 16, 2020
BioMed X announced the start of a new joint research group in collaboration with Boehringer Ingelheim at the BioMed X Innovation Center in Heidelberg.
-
BioMed X Reaches Milestone in Respiratory Disease Research Collaboration with Boehringer Ingelheim
b3cnewswire
December 04, 2019
BioMed X announced the successful completion of their first joint research project with Boehringer Ingelheim in the fields of chronic obstructive pulmonary disease (COPD) ...
-
BioMed X Completes Alzheimer’s Disease Research Project
b3cnewswire
October 29, 2019
BioMed X announced the successful completion of their first research collaboration project with AbbVie in the field of tau-mediated neurodegeneration in Alzheimer’s disease.
-
Velabs Therapeutics to Cooperate with BioMed X in the Field of Immunology
b3cnewswire
January 08, 2019
Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, today announced that it has entered into a collaboration agreement with BioMed X Innovation Center.....
-
BioMed X, Roche Enter Immunology Research Pact
contractpharma
March 13, 2018
BioMed X has entered a new research collaboration with F. Hoffmann-La Roche in the field of immunology